Characterisation of COPD / COPD clinic study

• Research type

  Research Study

• Full title

  Phenotypic Characterisation of COPD patients from outpatient respiratory clinics

• IRAS ID

  169111

• Sponsor organisation

  Medicines Evaluation Unit Ltd

• Duration of Study in the UK

  10 years, 0 months, 0 days

• Research summary

  Chronic Obstructive Pulmonary Disease (COPD) causes significant death and disability, with 3 million people affected in the UK. COPD is characterised by a gradual decline in lung function, shortness of breath, wheeze and a daily cough productive of phlegm. Exacerbations or “flare ups” are a common problem of COPD. Exacerbation means worsening of symptoms that requires the use of antibiotic, prednisolone (steroid tablets), changes in medications or possibly hospital admission. Several subgroups of COPD are now known to exist both when the patients are stable (not suffering a “flare up”) or during an exacerbation. This is an observational study of COPD. The aim of this study is to further improve our understanding of COPD and the different subgroups of patients that exist. This will be achieved by collecting and analysing the information collected on tests during usual clinical care and from some extra tests that are not part of usual clinical care. Patients will be identified from outpatient respiratory clinics but if enrolled in the study they may choose whether to take part in the extra tests. We will collect data for approximately 10 years but patient involvement will depend on the length of their clinical care and their willingness to participate in the study.

• REC name

  North West - Greater Manchester South Research Ethics Committee

• REC reference

  15/NW/0002

• Date of REC Opinion

  11 May 2015

• REC opinion

  Further Information Favourable Opinion